These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 19961738)
1. [Leptin promotes neointimal formation by stimulating vascular smooth muscle cell proliferation through leptin receptor]. Shen YC; He ZC; Lu DF; Ou BR; Pan JZ; Wang XM; Li J Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jul; 37(7):634-8. PubMed ID: 19961738 [TBL] [Abstract][Full Text] [Related]
2. Leptin regulates neointima formation after arterial injury through mechanisms independent of blood pressure and the leptin receptor/STAT3 signaling pathways involved in energy balance. Bodary PF; Shen Y; Ohman M; Bahrou KL; Vargas FB; Cudney SS; Wickenheiser KJ; Myers MG; Eitzman DT Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):70-6. PubMed ID: 17095713 [TBL] [Abstract][Full Text] [Related]
3. Increased neointimal formation after surgical vein grafting in a murine model of type 2 diabetes. Salzberg SP; Filsoufi F; Anyanwu A; von Harbou K; Karlof E; Carpentier A; Dansky HM; Adams DH Circulation; 2006 Jul; 114(1 Suppl):I302-7. PubMed ID: 16820590 [TBL] [Abstract][Full Text] [Related]
4. Endothelial NO synthase deficiency promotes smooth muscle progenitor cells in association with upregulation of stromal cell-derived factor-1alpha in a mouse model of carotid artery ligation. Zhang LN; Wilson DW; da Cunha V; Sullivan ME; Vergona R; Rutledge JC; Wang YX Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):765-72. PubMed ID: 16456092 [TBL] [Abstract][Full Text] [Related]
5. Transcription factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitro. Sakata Y; Xiang F; Chen Z; Kiriyama Y; Kamei CN; Simon DI; Chin MT Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2069-74. PubMed ID: 15345511 [TBL] [Abstract][Full Text] [Related]
7. Neointimal formation after endovascular arterial injury is markedly attenuated in db/db mice. Stephenson K; Tunstead J; Tsai A; Gordon R; Henderson S; Dansky HM Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2027-33. PubMed ID: 14500292 [TBL] [Abstract][Full Text] [Related]
8. Role of endogenous Fas (CD95/Apo-1) ligand in balloon-induced apoptosis, inflammation, and neointima formation. Matter CM; Chadjichristos CE; Meier P; von Lukowicz T; Lohmann C; Schuler PK; Zhang D; Odermatt B; Hofmann E; Brunner T; Kwak BR; Lüscher TF Circulation; 2006 Apr; 113(15):1879-87. PubMed ID: 16606788 [TBL] [Abstract][Full Text] [Related]
9. Selective Deletion of Leptin Signaling in Endothelial Cells Enhances Neointima Formation and Phenocopies the Vascular Effects of Diet-Induced Obesity in Mice. Hubert A; Bochenek ML; Schütz E; Gogiraju R; Münzel T; Schäfer K Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1683-1697. PubMed ID: 28705795 [TBL] [Abstract][Full Text] [Related]
10. Crucial role of stromal cell-derived factor-1alpha in neointima formation after vascular injury in apolipoprotein E-deficient mice. Schober A; Knarren S; Lietz M; Lin EA; Weber C Circulation; 2003 Nov; 108(20):2491-7. PubMed ID: 14581398 [TBL] [Abstract][Full Text] [Related]
12. Deficiency of tumour necrosis factor-alpha and interferon-gamma in bone marrow cells synergistically inhibits neointimal formation following vascular injury. Murayama H; Takahashi M; Takamoto M; Shiba Y; Ise H; Koyama J; Tagawa Y; Iwakura Y; Ikeda U Cardiovasc Res; 2008 Nov; 80(2):175-80. PubMed ID: 18791204 [TBL] [Abstract][Full Text] [Related]
13. Role of the angiotensin II type 2 receptor in arterial remodeling after wire injury in mice. Yamamoto Y; Watari Y; Brydun A; Yoshizumi M; Akishita M; Horiuchi M; Chayama K; Oshima T; Ozono R Hypertens Res; 2008 Jun; 31(6):1241-9. PubMed ID: 18716374 [TBL] [Abstract][Full Text] [Related]
14. Temporal and spatial characterization of cellular constituents during neointimal hyperplasia after vascular injury: Potential contribution of bone-marrow-derived progenitors to arterial remodeling. Shoji M; Sata M; Fukuda D; Tanaka K; Sato T; Iso Y; Shibata M; Suzuki H; Koba S; Geshi E; Katagiri T Cardiovasc Pathol; 2004; 13(6):306-12. PubMed ID: 15556776 [TBL] [Abstract][Full Text] [Related]
15. Interferon-γ deficiency reduces neointimal formation in a model of endoluminal endothelial injury combined with atherogenic diet. Tavakoli NN; Harris AK; Sullivan DR; Hambly BD; Bao S Int J Mol Med; 2012 Sep; 30(3):545-52. PubMed ID: 22710604 [TBL] [Abstract][Full Text] [Related]
16. Neutralization of interleukin-18 inhibits neointimal formation in a rat model of vascular injury. Maffia P; Grassia G; Di Meglio P; Carnuccio R; Berrino L; Garside P; Ianaro A; Ialenti A Circulation; 2006 Aug; 114(5):430-7. PubMed ID: 16864728 [TBL] [Abstract][Full Text] [Related]
17. Phytoestrogen derivatives differentially inhibit arterial neointimal proliferation in a mouse model. Shen J; White M; Husband AJ; Hambly BD; Bao S Eur J Pharmacol; 2006 Oct; 548(1-3):123-8. PubMed ID: 16950243 [TBL] [Abstract][Full Text] [Related]
18. Stem cell factor deficiency is vasculoprotective: unraveling a new therapeutic potential of imatinib mesylate. Wang CH; Anderson N; Li SH; Szmitko PE; Cherng WJ; Fedak PW; Fazel S; Li RK; Yau TM; Weisel RD; Stanford WL; Verma S Circ Res; 2006 Sep; 99(6):617-25. PubMed ID: 16931795 [TBL] [Abstract][Full Text] [Related]
19. Protective role of clusterin/apolipoprotein J against neointimal hyperplasia via antiproliferative effect on vascular smooth muscle cells and cytoprotective effect on endothelial cells. Kim HJ; Yoo EK; Kim JY; Choi YK; Lee HJ; Kim JK; Jeoung NH; Lee KU; Park IS; Min BH; Park KG; Lee CH; Aronow BJ; Sata M; Lee IK Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1558-64. PubMed ID: 19696405 [TBL] [Abstract][Full Text] [Related]
20. Central role of endogenous Toll-like receptor-2 activation in regulating inflammation, reactive oxygen species production, and subsequent neointimal formation after vascular injury. Shishido T; Nozaki N; Takahashi H; Arimoto T; Niizeki T; Koyama Y; Abe J; Takeishi Y; Kubota I Biochem Biophys Res Commun; 2006 Jul; 345(4):1446-53. PubMed ID: 16730663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]